JP2019506866A5 - - Google Patents

Download PDF

Info

Publication number
JP2019506866A5
JP2019506866A5 JP2018540841A JP2018540841A JP2019506866A5 JP 2019506866 A5 JP2019506866 A5 JP 2019506866A5 JP 2018540841 A JP2018540841 A JP 2018540841A JP 2018540841 A JP2018540841 A JP 2018540841A JP 2019506866 A5 JP2019506866 A5 JP 2019506866A5
Authority
JP
Japan
Prior art keywords
igg
polypeptide
protease activity
cysteine protease
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018540841A
Other languages
English (en)
Japanese (ja)
Other versions
JP7123801B2 (ja
JP2019506866A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2017/052463 external-priority patent/WO2017134274A1/en
Publication of JP2019506866A publication Critical patent/JP2019506866A/ja
Publication of JP2019506866A5 publication Critical patent/JP2019506866A5/ja
Priority to JP2022056522A priority Critical patent/JP2022115853A/ja
Application granted granted Critical
Publication of JP7123801B2 publication Critical patent/JP7123801B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018540841A 2016-02-04 2017-02-03 新しい連鎖球菌プロテアーゼ Active JP7123801B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022056522A JP2022115853A (ja) 2016-02-04 2022-03-30 新しい連鎖球菌プロテアーゼ

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE1630021 2016-02-04
SE1630021-2 2016-02-04
PCT/EP2017/052463 WO2017134274A1 (en) 2016-02-04 2017-02-03 New streptococcal proteases

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022056522A Division JP2022115853A (ja) 2016-02-04 2022-03-30 新しい連鎖球菌プロテアーゼ

Publications (3)

Publication Number Publication Date
JP2019506866A JP2019506866A (ja) 2019-03-14
JP2019506866A5 true JP2019506866A5 (enExample) 2020-03-12
JP7123801B2 JP7123801B2 (ja) 2022-08-23

Family

ID=57995190

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018540841A Active JP7123801B2 (ja) 2016-02-04 2017-02-03 新しい連鎖球菌プロテアーゼ
JP2022056522A Withdrawn JP2022115853A (ja) 2016-02-04 2022-03-30 新しい連鎖球菌プロテアーゼ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022056522A Withdrawn JP2022115853A (ja) 2016-02-04 2022-03-30 新しい連鎖球菌プロテアーゼ

Country Status (13)

Country Link
US (1) US12006530B2 (enExample)
EP (1) EP3411389B1 (enExample)
JP (2) JP7123801B2 (enExample)
KR (1) KR102704583B1 (enExample)
CN (1) CN109311951B (enExample)
AU (1) AU2017214441B2 (enExample)
CA (1) CA3013527C (enExample)
DK (1) DK3411389T3 (enExample)
ES (1) ES2877754T3 (enExample)
PL (1) PL3411389T3 (enExample)
PT (1) PT3411389T (enExample)
SG (1) SG11201806639VA (enExample)
WO (1) WO2017134274A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3387898T (pt) 2013-03-15 2020-06-17 Mayo Found Medical Education & Res Identificação e monitorização de imunoglobulinas monoclonais pela massa molecular
EP3126826B1 (en) 2014-04-04 2020-12-16 Mayo Foundation for Medical Education and Research Isotyping immunoglobulins using accurate molecular mass
WO2017053932A1 (en) 2015-09-24 2017-03-30 Mayo Foundation For Medical Education And Research Identification of immunoglobulin free light chains by mass spectrometry
PL3411389T3 (pl) 2016-02-04 2021-10-25 Genovis Ab Nowe proteazy streptokokowe
AU2017325022B2 (en) 2016-09-07 2022-10-13 Mayo Foundation For Medical Education And Research Identification and monitoring of cleaved immunoglobulins by molecular mass
KR102608876B1 (ko) 2017-05-26 2023-11-30 게노비스 에이비 글리칸 분석을 위한 효소
US20210228738A1 (en) 2017-07-17 2021-07-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Compositions and methods for increasing or enhancing transduction of gene therapy vectors and for removing or reducing immunoglobulins
WO2019055634A1 (en) 2017-09-13 2019-03-21 Mayo Foundation For Medical Education And Research IDENTIFICATION AND MONITORING OF A MACROPHAGE APOPTOSIS INHIBITOR
US12153052B2 (en) 2017-09-13 2024-11-26 Mayo Foundation For Medical Education And Research Identification and monitoring of immunoglobulin J chains
JP7425728B2 (ja) * 2017-12-15 2024-01-31 インターベット インターナショナル ベー. フェー. レンサ球菌感染防御のためのワクチン
WO2021067598A1 (en) 2019-10-04 2021-04-08 Ultragenyx Pharmaceutical Inc. Methods for improved therapeutic use of recombinant aav
EP4103724A1 (en) 2020-02-14 2022-12-21 Ultragenyx Pharmaceutical Inc. Gene therapy for treating cdkl5 deficiency disorder
GB202002072D0 (en) * 2020-02-14 2020-04-01 Hansa Biopharma AB immunoglobulin detection and associated therapies
US20230364207A1 (en) * 2020-06-18 2023-11-16 Shanghai Bao Pharmaceuticals Co., Ltd. Mutant of immunoglobulin degrading enzyme idee
JP2023545731A (ja) 2020-10-07 2023-10-31 アスクレピオス バイオファーマシューティカル, インコーポレイテッド 肢帯型2i(lgmd2i)を含むジストログリカノパチー障害を処置するためのフクチン関連タンパク質(fkrp)の治療的アデノ随伴ウイルス送達
EP4323015A4 (en) 2021-04-16 2025-10-22 Askbio Inc RATIONALLY POLYPLOID AAV VIRIONS CROSS THE BLOOD-BRAIN BARRIER AND TRIGGER A REDUCED HUMORAL RESPONSE
EP4079848A1 (en) 2021-04-22 2022-10-26 Genovis Ab Immunoglobulin cleaving enzyme
WO2022266044A1 (en) * 2021-06-15 2022-12-22 The University Of North Carolina At Chapel Hill Methods and compositions for depleting antibodies
JP2024531138A (ja) 2021-08-11 2024-08-29 ウルトラジェニックス ファーマシューティカル インコーポレイテッド 筋ジストロフィーを処置するための組成物および方法
CN118265540A (zh) * 2021-11-18 2024-06-28 英特维特国际股份有限公司 产生针对猪链球菌的疫苗的方法以及所述疫苗
CN120265651A (zh) * 2022-11-25 2025-07-04 中外制药株式会社 用于生产蛋白质的方法
WO2025047641A1 (ja) 2023-08-25 2025-03-06 積水メディカル株式会社 免疫学的測定方法、免疫学的測定用試薬、免疫学的測定用検体前処理液、及び免疫学的測定用試薬キット、非特異反応抑制剤
WO2025256978A1 (en) 2024-06-13 2025-12-18 Bayer Aktiengesellschaft Variants of igm and igg cleaving enzymes
WO2025256977A1 (en) 2024-06-13 2025-12-18 Bayer Aktiengesellschaft Novel igm and igg cleaving enzymes

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2824074A1 (fr) 2001-04-26 2002-10-31 Pasteur Institut Sequence du genome streptococcus agalactiae, application au developpement de vaccins, d'outils de diagnostic, et a l'identification de cibles therapeutiques
GB0130228D0 (en) * 2001-12-18 2002-02-06 Hansa Medica Ab Protein
AU2005319174A1 (en) 2004-12-22 2006-06-29 J. Craig Venter Institute, Inc. Group B Streptococcus
ES2380950T3 (es) 2005-06-09 2012-05-21 Hansa Medical Ab Uso de la proteinasa IdeS ( de S, pyogenes) para tratar enfermedades autoinmunitarias y rechazo de injerto
WO2009033670A2 (en) 2007-09-14 2009-03-19 Genovis Ab Method and kits for dissociating fcgamma-receptor-igg complexes and for igg purification and detection
GB201115841D0 (en) * 2011-09-13 2011-10-26 Genovis Ab Protein and method
GB201316744D0 (en) 2013-09-20 2013-11-06 Genovis Ab Method
PL3411389T3 (pl) 2016-02-04 2021-10-25 Genovis Ab Nowe proteazy streptokokowe

Similar Documents

Publication Publication Date Title
JP2019506866A5 (enExample)
JP2014531205A5 (enExample)
KR20130135028A (ko) 동물로부터 단일클론 항체의 고속 분리
PH12015502849B1 (en) Biomarkers for cognitive dysfunction diseases and method for detecting cognitive dysfunction disease using biomarkers
WO2015112558A3 (en) Peptides, devices, and methods for the detection of anaplasma antibodies
RU2016129161A (ru) Усовершенствованный диагностический тест для csfv антител
FI20165814A7 (fi) Interleukiini 8 (il-8) prognostisena ja ennustavana biomarkkerina ja koostumukset ja vektorit käytettäväksi onkolyyttisessa immunoterapiassa
JP2019507341A5 (enExample)
AU2018274704A1 (en) Assay for plasma cell associated disease
Pastor-Fernandez et al. Characterization of the Neospora caninum NcROP40 and NcROP2Fam-1 rhoptry proteins during the tachyzoite lytic cycle
Qiu et al. Identification of a TNF-α inducer MIC3 originating from the microneme of non-cystogenic, virulent Toxoplasma gondii
JP2020522242A5 (enExample)
WO2017125892A3 (es) Anticuerpos monoclonales específicos para el antígeno piii de adenovirus humano (adv), producidos y secretados por hibridomas celulares, útiles para la detección y el diagnóstico de la infección causada por adv
Schröder Discovery of natural bispecific antibodies: Is psoriasis induced by a toxigenic Corynebacterium simulans and maintained by CIDAMPs as autoantigens?
CN108276480A (zh) Pcv3抗原表位的多肽序列筛选方法
Matysiak et al. Association between venom immunotherapy and changes in serum protein—Peptide patterns
CN103336133A (zh) 一种用于检测抗mda5抗体的试剂盒及其检测方法
SG10201903424RA (en) ANTI HUMAN Gas6 MONOCLONAL ANTIBODY
GB2541596A (en) Method and composition for determining specific antibody responses to species of filovirus
Reed et al. Novel mass spectrometry based detection and identification of variants of rabies virus nucleoprotein in infected brain tissues
De Filette et al. T cell epitope mapping of the e-protein of West Nile virus in BALB/c mice
WO2013042917A3 (ko) 중공사막을 이용한 단백질의 효소 처리장치 및 이를 이용한 온-라인 프로테오믹스 방법
ZA202302763B (en) Hydrophobic interaction chromatography-coupled native mass spectrometry for antibody analysis
CN101560245B (zh) 一种禽流感h5n1病毒的ctl表位多肽及其应用
MX2022005611A (es) Peptidos antigenicos de enolasa especificos de neuronas para el diagnostico y el tratamiento del autismo.